mTOR抑制剂-话题@MedSci

#mTOR抑制剂#

14篇内容 | 824人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1489897, encodeId=ef94148989ea2, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Clin Cancer Res：mTOR抑制剂sapanisertib联合氟维司群治疗芳香化酶抑制剂进展后ER+/ HER2-的绝经后女性晚期乳腺癌患者的疗效, objectType=article, longId=293538, objectId=db002935384a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db002935384a, replyNumber=0, likeNumber=33, createdTime=2022-01-08, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db002935384a, moduleTitle=Clin Cancer Res：mTOR抑制剂sapanisertib联合氟维司群治疗芳香化酶抑制剂进展后ER+/ HER2-的绝经后女性晚期乳腺癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db002935384a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489896, encodeId=f29e14898965c, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Clin Cancer Res：首次人源性I期研究评估了PI3K/mTOR抑制剂GDC-0084在胶质瘤患者中的应用, objectType=article, longId=293008, objectId=928829300830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=928829300830, replyNumber=0, likeNumber=31, createdTime=2021-12-30, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=928829300830, moduleTitle=Clin Cancer Res：首次人源性I期研究评估了PI3K/mTOR抑制剂GDC-0084在胶质瘤患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=928829300830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489895, encodeId=379a1489895e6, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Liver Cnacer：mTOR抑制剂Temsirolimus联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：II期临床研究, objectType=article, longId=216786, objectId=af4a216e8623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4a216e8623, replyNumber=0, likeNumber=29, createdTime=2021-09-09, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4a216e8623, moduleTitle=Liver Cnacer：mTOR抑制剂Temsirolimus联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4a216e8623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489894, encodeId=60dc14898947e, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Clin Cancer Res：首次人源性I期研究评估了PI3K/mTOR抑制剂GDC-0084在胶质瘤患者中的应用, objectType=article, longId=209923, objectId=cb352099230f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb352099230f, replyNumber=0, likeNumber=48, createdTime=2021-04-15, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb352099230f, moduleTitle=Clin Cancer Res：首次人源性I期研究评估了PI3K/mTOR抑制剂GDC-0084在胶质瘤患者中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb352099230f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489893, encodeId=82cb148989315, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Phenformin联合mTOR抑制剂在HCC中显示出治疗希望, objectType=article, longId=141922, objectId=863314192247, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=863314192247, replyNumber=0, likeNumber=43, createdTime=2018-06-30, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=863314192247, moduleTitle=Phenformin联合mTOR抑制剂在HCC中显示出治疗希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=863314192247)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489892, encodeId=17e7148989251, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Lancet oncol：Buparlisib联合氟维司群用于内分泌疗法和mTOR抑制剂治疗失败的雌激素受体阳性、HER2阴性的晚期乳腺癌患者的效果和安全性。, objectType=article, longId=122620, objectId=45fb122620ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45fb122620ba, replyNumber=0, likeNumber=27, createdTime=2017-12-08, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45fb122620ba, moduleTitle=Lancet oncol：Buparlisib联合氟维司群用于内分泌疗法和mTOR抑制剂治疗失败的雌激素受体阳性、HER2阴性的晚期乳腺癌患者的效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45fb122620ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489891, encodeId=a2e0148989103, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Science：mTOR抑制剂具有治疗IL10突变的炎症性肠炎病人的潜力, objectType=article, longId=97947, objectId=b0569e947ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0569e947ae, replyNumber=0, likeNumber=37, createdTime=2017-05-07, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0569e947ae, moduleTitle=Science：mTOR抑制剂具有治疗IL10突变的炎症性肠炎病人的潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0569e947ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489890, encodeId=19d8148989068, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=PNAS：上海交大研究人员揭示mTOR抑制剂对DNMT3A突变相关白血病的治疗作用, objectType=article, longId=97941, objectId=15219e941ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15219e941ef, replyNumber=0, likeNumber=36, createdTime=2017-05-06, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15219e941ef, moduleTitle=PNAS：上海交大研究人员揭示mTOR抑制剂对DNMT3A突变相关白血病的治疗作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15219e941ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489889, encodeId=a1a914898898e, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Nature：新一代靶向mTOR抑制剂，1+1>2的“合体”抗癌药, objectType=article, longId=69287, objectId=b78c6928e4d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b78c6928e4d, replyNumber=0, likeNumber=31, createdTime=2016-05-28, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b78c6928e4d, moduleTitle=Nature：新一代靶向mTOR抑制剂，1+1>2的“合体”抗癌药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b78c6928e4d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489888, encodeId=9a6f1489888f9, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Nature：新一代mTOR抑制剂有望治疗多种耐药性肿瘤, objectType=article, longId=68826, objectId=a6816882636, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6816882636, replyNumber=0, likeNumber=30, createdTime=2016-05-23, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6816882636, moduleTitle=Nature：新一代mTOR抑制剂有望治疗多种耐药性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6816882636)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489887, encodeId=f270148988e97, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=Clin Cancer Res：MEK抑制剂单独或联合mTOR抑制剂对头颈部鳞状细胞癌的抗肿瘤作用, objectType=article, longId=50869, objectId=694b508695d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=694b508695d, replyNumber=0, likeNumber=24, createdTime=2015-05-19, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=694b508695d, moduleTitle=Clin Cancer Res：MEK抑制剂单独或联合mTOR抑制剂对头颈部鳞状细胞癌的抗肿瘤作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=694b508695d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489886, encodeId=95f91489886fe, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=JECM：新型双重AMPK激活/mTOR抑制剂可抑制甲状腺癌细胞生长, objectType=article, longId=48827, objectId=47b34882e3d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47b34882e3d, replyNumber=0, likeNumber=30, createdTime=2015-04-02, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47b34882e3d, moduleTitle=JECM：新型双重AMPK激活/mTOR抑制剂可抑制甲状腺癌细胞生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47b34882e3d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489885, encodeId=c0fb148988575, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=mTOR抑制剂依维莫司在乳腺癌中的地位尚待确立（BOLERO研究）, objectType=article, longId=27188, objectId=713f2e18889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=713f2e18889, replyNumber=0, likeNumber=37, createdTime=2013-11-29, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=713f2e18889, moduleTitle=mTOR抑制剂依维莫司在乳腺癌中的地位尚待确立（BOLERO研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=713f2e18889)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1489884, encodeId=ecb2148988456, content=<a href='/topic/show?id=df661233631' target=_blank style='color:#2F92EE;'>#mTOR抑制剂#</a>, objectTitle=AI+mTOR抑制剂内分泌联合靶向治疗乳腺癌的又一尝试, objectType=article, longId=3778, objectId=a4a63e781d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4a63e781d, replyNumber=0, likeNumber=42, createdTime=2012-01-27, rootId=0, userName=yankaienglish, userId=7f708628038, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4a63e781d, moduleTitle=AI+mTOR抑制剂内分泌联合靶向治疗乳腺癌的又一尝试, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4a63e781d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

mTOR抑制剂

2020-05-29

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Clin Cancer Res：mTOR抑制剂sapanisertib联合氟维司群治疗芳香化酶抑制剂进展后ER+/ HER2-的绝经后女性晚期乳腺癌患者的疗效

2022-01-08

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Clin Cancer Res：首次人源性I期研究评估了PI3K/mTOR抑制剂GDC-0084在胶质瘤患者中的应用

2021-12-30

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Liver Cnacer：mTOR抑制剂Temsirolimus联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：II期临床研究

2021-09-09

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Clin Cancer Res：首次人源性I期研究评估了PI3K/mTOR抑制剂GDC-0084在胶质瘤患者中的应用

2021-04-15

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Phenformin联合mTOR抑制剂在HCC中显示出治疗希望

2018-06-30

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Lancet oncol：Buparlisib联合氟维司群用于内分泌疗法和mTOR抑制剂治疗失败的雌激素受体阳性、HER2阴性的晚期乳腺癌患者的效果和安全性。

2017-12-08

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Science：mTOR抑制剂具有治疗IL10突变的炎症性肠炎病人的潜力

2017-05-07

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

PNAS：上海交大研究人员揭示mTOR抑制剂对DNMT3A突变相关白血病的治疗作用

2017-05-06

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Nature：新一代靶向mTOR抑制剂，1+1>2的“合体”抗癌药

2016-05-28

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Nature：新一代mTOR抑制剂有望治疗多种耐药性肿瘤

2016-05-23

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

Clin Cancer Res：MEK抑制剂单独或联合mTOR抑制剂对头颈部鳞状细胞癌的抗肿瘤作用

2015-05-19

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

JECM：新型双重AMPK激活/mTOR抑制剂可抑制甲状腺癌细胞生长

2015-04-02

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

mTOR抑制剂依维莫司在乳腺癌中的地位尚待确立（BOLERO研究）

2013-11-29

yankaienglish (审核中...)

前往app查看评论内容

#mTOR抑制剂#

AI+mTOR抑制剂内分泌联合靶向治疗乳腺癌的又一尝试

2012-01-27

科室
- - 订阅+
  - 更多科室
工具
服务